3
Views
21
CrossRef citations to date
0
Altmetric
Gene Expression

Identification of a Pancreatic β-Cell Insulin Gene Transcription Factor That Binds to and Appears To Activate Cell-Type-Specific Expression: Its Possible Relationship to Other Cellular Factors That Bind to a Common Insulin Gene Sequence

, , , &
Pages 1564-1572 | Received 29 Sep 1989, Accepted 21 Dec 1989, Published online: 31 Mar 2023

Literature Cited

  • Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729–739.
  • Barberis, A., S. F. Giulio, and M. Busslinger. 1987. Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter. Cell 50:347–359.
  • Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoterspecific transcription factor, Spl. Science 234:47–52.
  • Carthew, R. W., L. A. Chodosh, and P. A. Sharp. 1985. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 43:439–448.
  • Chan, S. J., V. Episkopou, S. Zeitlin, S. K. Karathanasis, A. Mac Kreil, D. F. Steiner, and A. Efstratiadis. 1984. Guinea pig preproinsulin gene: an evolutionary compromise? Proc. Natl. Acad. Sci. USA 81:5046–5050.
  • Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
  • Clark, J. L., and D. F. Steiner. 1969. Insulin biosynthesis in the rat: demonstration of two proinsulins. Proc. Natl. Acad. Sci. USA 62:278–285.
  • Cordell, B., D. Diamond, S. Smith, J. Punter, H. H. Schone, and H. M. Goodman. 1982. Disproportionate expression of the two insulin nonallelic rat insulin genes in a pancreatic tumor is due to translational control. Cell 31:531–542.
  • Crowe, D. T., and M. Tsai. 1989. Mutagenesis of the rat insulin II 5'-flanking region defines sequences important for expression in HIT cells. Mol. Cell. Biol. 9:1784–1789.
  • Edlund, T., M. D. Walker, P. J. Barr, and W. J. Rutter. 1985. Cell-specific expression of the rat insulin gene: evidence for the role of two distinct 5' flanking sequences. Science 230:912–916.
  • Efrat, S., S. Linde, H. Kofod, D. Spector, M. Delannoy, S. Grant, D. Hanahan, and S. Baekkeskov. 1988. Beta cell lines derived from transgenic mice expressing a hybrid insulin geneoncogene. Proc. Natl. Acad. Sci. USA 85:9037–9041.
  • Ephrussi, A., G. M. Church, S. Tonegawa, and W. Gilbert. 1985. B-lineage specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134–140.
  • Episkopou, V., A. J. M. Murphy, and A. Efstratiadis. 1984. Cell-specific expression of a selectable hybrid gene. Proc. Natl. Acad. Sci. USA 81:4657–4661.
  • Goodbourn, S., H. Burstein, and T. Maniatis. 1986. The human β-interferon gene enhancer is under negative control. Cell 45:601–610.
  • Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767–776.
  • Hanahan, D. 1985. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/ simian virus 40 oncogenes. Nature (London) 315:115–122.
  • Hatzopoulos, A. K., U. Schlokat, and P. Gruss. 1988. Enhancers and cis-acting regulatory sequences, p. 43–96. In B. D. Hames and D. M. Glover (ed.), Eucaryotic RNA synthesis and processing, horizons in molecular biology series. IRL Press, Oxford.
  • Hoeffler, W. K., R. Kovelman, and R. G. Roeder. 1988. Activation of transcription factor IIIC by the adenovirus E1A protein. Cell 53:907–920.
  • Johnson, P. F., W. H. Landschulz, B. J. Graves, and S. L. Me Knight. 1987. Identification of a rat liver protein that binds to the enhancer core element of three animal viruses. Genes Dev. 1:133–146.
  • Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48:79–89.
  • Karlsson, O., T. Edlund, J. B. Moss, W. J. Rutter, and M. D. Walker. 1987. A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc. Natl. Acad. Sci. USA 84:8819–8823.
  • Karlsson, O., M. D. Walker, W. J. Rutter, and T. Edlund. 1989. Individual protein-binding domains of the insulin gene enhancer positively activate β-cell-specific transcription. Mol. Cell Biol. 9:823–827.
  • Landolfi, N. F., J. D. Capra, and P. W. Tucker. 1986. Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequence. Nature (London) 323:548–551.
  • Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible elements. Cell 49:741–751.
  • Levine, M., and J. L. Manley. 1989. Transcriptional repression of eukaryotic promoters. Cell 59:405–408.
  • Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Maniatis, T., S. Goodbourne, and J. A. Fischer. 1987. Regulation of inducible and tissue-specific gene expression. Science 236:1237–1244.
  • McKnight, S. L., E. R. Gavis, and R. Kingsbury. 1981. Analysis of transcription regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell 25:385–398.
  • Melton, D. A., P. H. Kreig, M. R. Rebagiiati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035–7056.
  • Moss, L. G., J. B. Moss, and W. J. Rutter. 1988. Systematic binding analysis of the insulin gene transcription control region: insulin and immunoglobulin enhancers utilize similar transactivators. Mol. Cell. Biol. 8:2620–2627.
  • Murre, C., P. S. McCaw, and D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777–783.
  • Murre, C., P. S. McCaw, H. Vaessin, M. Cudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537–544.
  • Ohlsson, H., and T. Edlund. 1988. A β-cell-specific protein binds to two major regulatory sequences of the insulin gene enhancer. Proc. Natl. Acad. Sci. USA 85:4228–4231.
  • Ondek, B., A. Shepard, and W. Herr. 1987. Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities. EMBO J. 6:1017–1025.
  • Pettersson, M., and W. Schaffner. 1987. A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells. Genes Dev. 1:962–972.
  • Plumb, M. A., V. V. Lobanenkov, R. H. Nicolas, C. A. Wright, S. Zavon, and G. H. Goodwin. 1986. Characterization of chicken erythroid proteins which bind to the nuclease hypersensitive regions upstream of the βΑ- and βH-globin genes. Nucleic Acids Res. 19:7675–7693.
  • Prywes, R., and R. G. Roeder. 1986. Inducible binding of a factor to the c-fos enhancer. Cell 47:777–784.
  • Sakonju, S., and D. D. Brown. 1982. Contact points between a positive transcription factor and the Xenopus 5S RNA gene. Cell 31:395–405.
  • Sawadogo, M., and R. G. Roeder. 1985. Interaction of a genespecific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43:165–175.
  • Scholer, H., and P. Gruss. 1985. Cell-type specific enhancement in vitro requires the presence of trans-acting factors. EMBO J. 4:3005–3013.
  • Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705–716.
  • Sen, R., and D. Baltimore. 1986. Inducibility of κ immunoglobulin enhancer-binding protein NF-κΒ by a posttranslational mechanism. Cell 47:921–928.
  • Shapiro, D. J., P. A. Sharp, W. W. Wahli, and M. Keller. 1988. A high-efficiency HeLa cell nuclear transcription extract. DNA 1:47–55.
  • Sorger, P. K., M. J. Lewis, and H. R. B. Pelham. 1987. Heat shock factors regulated differentially in yeast and HeLa cells. Nature (London) 329:81–84.
  • Staudt, L. M., H. S. Singh, R. Sen, T. Wirth, P. A. Sharp, and D. Baltimore. 1986. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (London) 323:640–643.
  • Stein, R. W., and J. Whelan. 1989. Insulin gene activity is inhibited by adenovirus 5 Ela gene products. Mol. Cell. Biol. 9:4531–4534.
  • Walker, M. D., T. Edlund, A. M. Boulet, and W. J. Rutter. 1983. Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes. Nature (London) 306:557–561.
  • Westin, G., T. Gerster, M. M. Muller, G. Schaffner, and W. Schaffner. 1987. OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts. Nucleic Acids Res. 15:6787–6798.
  • Whelan, J., D. Poon, P. A. Weil, and R. Stein. 1989. Pancreatic β-cell-type-specific expression of the rat insulin II gene is controlled by positive and negative transcriptional elements. Mol. Cell. Biol. 9:3253–3259.
  • Xiao, J. H., I. Davidson, D. Ferrandon, R. Rosales, M. Vigneron, M. Macchi, F. Ruffenach, and P. Chambon. 1987. One cell specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in domain Bl of the SV40 enhancer. EMBO J. 6:3015–3025.
  • Yu, H., B. Porton, L. Shen, and L. A. Eckhardt. 1989. Role of the octamer motif in hybrid cell extinction of immunoglobulin gene expression: extinction is dominant in a two enhancer system. Cell 58:441–448.
  • Zinn, K., D. Di Maio, and T. Maniatis. 1983. Identification of two distinct regulatory regions adjacent to the human β-interferon gene. Cell 34:865–879.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.